Eclat Pharmaceutical
Avadel is a biopharmaceutical company dedicated to transforming medicines to enhance the quality of life for patients. Their innovative product, LUMRYZ, has been approved by the FDA as the first and only once-at-bedtime oxybate for treating cataplexy or excessive daytime sleepiness in patients aged 7 and older with narcolepsy.
With a strong focus on patient safety, Avadel promotes responsible use of LUMRYZ through a restricted distribution program, ensuring that healthcare providers and pharmacists are specially certified. The company is committed to addressing the risks associated with central nervous system depression and potential abuse, while actively monitoring the emerging needs of their patient population.
Generated from the website
Also at this address
You might also like
Partial Data by Foursquare.